❯ Discover More

Barcoding
Technology

Barcoding Technology

Systasy at BioEurope 2024 Sweden

July 30th 2024

Multiplexable & Parallel Assays

Disease
Models

Human Disease Models

❯ Discover More

Single-Cell/Nucleus Sequencing Service

July 30, 2024

Patient Derived Cellular Model Systems

Systasy Bioscience GmbH is a privately owned technology provider offering a proprietary breakthrough DNA barcoding technology for highly multiplexed transcriptomic analysis at the single cell level. This cutting-edge innovation enables Systasy to collaborate with partners in two major and rapidly expanding fields in the pharmaceutical and biotech industries.

We aim to gain deep insights into disease mechanisms and accelerate the development of effective treatments. With our pathway-focused approach, targets and drug candidates discovered from our platform address the truly relevant disease causes and display a markedly increased likelihood of being highly effectives.

 

Our Technology

Systasy’s technology is unique as it uses millions of molecular barcodes combined with human disease models to analyze hundreds of pathological processes simultaneously. It connects thousands of compound activities to an individual patient’s clinical and genomic data. Systasy’s technology lowers failure in subsequent clinical phases and leads to cost savings for our partners.

Collaboration is part of our DNA!

Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.

Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.